Translational / Biotech research

Bionoor

Bionoor was founded in 2004 as an offshoot of the Bios International Innovative Health Care Division, . through its consolidated know-how in translational research. By integrating its experimental activities with clinical practice, Bionoor continuously transfers knowledge from its fundamental research to diagnostic applications. The research areas of excellence are focus ed on cardiovascular and dismetabolic pathologies, and genetic illnesses. Fundamental research, supported by a significant number of national and international patents, has led to the production of nutraceuticals (the Nurax family of products) and of diagnostic kits developed in collaboration with important research centers.